Literature DB >> 1919692

Natural history of the cavernous angioma.

J R Robinson1, I A Awad, J R Little.   

Abstract

The incidence and natural history of the cavernous angioma have remained unclear in part because of the difficulty of diagnosing and following this lesion prior to surgical excision. The introduction of magnetic resonance (MR) imaging has improved the sensitivity and specificity of diagnosing and following this vascular malformation. Seventy-six lesions with an MR appearance typical of a presumed cavernous angioma were discovered in 66 patients among 14,035 consecutive MR images performed at the Cleveland Clinic between 1984 and 1989. Follow-up studies in 86% of the cases over a mean period of 26 months provided 143 lesion-years of clinical survey of this condition. The most frequent presenting features were seizure, focal neurological deficit, and headache. While most lesions exhibited evidence of occult bleeding on MR imaging, there was overt hemorrhage in seven of the 57 symptomatic patients and only one overt hemorrhage occurred during the follow-up interval. The annualized bleeding rate was 0.7%. Analysis of the hemorrhage group revealed a significantly greater risk of overt hemorrhage in females. Pathological confirmation of cavernous angioma was obtained in all 14 surgical cases. This information assists in rational therapeutic planning and prognosis in patients with MR images showing lesions suggestive of cavernous angioma.

Entities:  

Mesh:

Year:  1991        PMID: 1919692     DOI: 10.3171/jns.1991.75.5.0709

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  137 in total

1.  Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q.

Authors:  L Notelet; F Chapon; S Khoury; K Vahedi; J P Chodkiewicz; P Courtheoux; M T Iba-Zizen; E A Cabanis; B Lechevalier; E Tournier-Lasserve; J P Houtteville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Surgical management of brain-stem cavernomas.

Authors:  U Pechstein; J Zentner; D Van Roost; J Schramm
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

Review 3.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

4.  Systems biology and proteomic analysis of cerebral cavernous malformation.

Authors:  Alexander R Edelmann; Sarah Schwartz-Baxter; Christopher F Dibble; Warren C Byrd; Jim Carlson; Ivandario Saldarriaga; Sompop Bencharit
Journal:  Expert Rev Proteomics       Date:  2014-03-31       Impact factor: 3.940

5.  Prospective Hemorrhage Rates of Cerebral Cavernous Malformations in Children and Adolescents Based on MRI Appearance.

Authors:  O Nikoubashman; F Di Rocco; I Davagnanam; K Mankad; M Zerah; M Wiesmann
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

6.  Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Authors:  Blaine L Hart; Saeid Taheri; Gary A Rosenberg; Leslie A Morrison
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

Review 7.  Endogenous endothelial cell signaling systems maintain vascular stability.

Authors:  Nyall R London; Kevin J Whitehead; Dean Y Li
Journal:  Angiogenesis       Date:  2009-01-27       Impact factor: 9.596

Review 8.  Intracranial haemorrhage in pregnancy.

Authors:  Jacob M Fairhall; Marcus A Stoodley
Journal:  Obstet Med       Date:  2009-11-30

Review 9.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

10.  Management of intracranial cavernous malformation in pediatric patients.

Authors:  Jae-Whan Lee; Dong-Seok Kim; Kyu-Won Shim; Jong-Hee Chang; Seung-Kon Huh; Yong-Gou Park; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.